NAYA (NAYA Biosciences) Pangali Forward P/E
NAYA Biosciences relies on external financing and grants, as it currently lacks operating income. The team brings together experts in reproductive medicine and oncology, attracted by stock option programs. The company's future P/E metric reflects the intensive validation of bispecific antibodies, with the value held at 0.00, which helps assess market expectations for the R&D pipeline.
Ringkesan rincian data analitis NAYA Biosciences Corp (NAYA)
- rega saiki lan proyeksi nilai saham:
- indikator valuasi pasar bisnis:
- informasi kapitalisasi buku:
- indikator beban kredit lan likuiditas emiten:
Total Utang marang Modal NAYA Biosciences|NAYA - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas NAYA Biosciences|NAYA - Utang agregat perusahaan|Utang-utang marang kapitalisasi buku NAYA Biosciences Inc|NAYA - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan NAYA Biosciences|Rasio cepet nayabiosciences.com
- rincian asil keuangan lan kelipatan valuasi:
NAYA - Bathi resik|Bathi mangsa ngarep NAYA Biosciences|NAYA - Nilai perusahaan marang bathi resik|Pangali Forward P/E NAYA Bio|NAYA - Rasio rega marang bathi tumrap wutah|Pangali EV/EBITDA NAYA Biosciences Inc|NAYA - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone rolas wulan pungkasan NAYA Biosciences|NAYA - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan nayabiosciences.com|NAYA - Prakiraan wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep NAYA Biosciences
- indikator volume dodolan lan pendapatan:
Ringkesan analitik perusahaan:NAYA Biosciences Inc.
The forward P/E compares current market capitalization with expected net income, reflecting market expectations regarding future business efficiency. By analyzing the current forward P/E level of NAYA Biosciences (NAYA), an investor performs a stress test on asset resilience, which is critical for NAYA Biosciences, as its valuation currently depends on the speculative assessment of success in deploying its oncology portfolio.
Analisis perusahaan pesaing
Prakiraan rega marang bathi ONC (BeiGene)|HALO (Halozyme Therapeutics, Inc.) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E RVMD (RevMed)|AAPG - Prakiraan rega marang bathi|CGON: Prakiraan rega marang bathi|URGN - Pangali Forward P/E|Bicara Therapeutics (BCAX) - Rega marang bathi mangsa ngarep|Personalis Inc - Pangali mangsa ngarep rega marang bathi|ERAS (Erasca Corp) - Pangali Forward P/E|Rasio prakiraan rega marang bathi Delcath Corp DCTH|Rega marang bathi mangsa ngarep Y-mAbs Therapeutics (YMAB)|aurabiosciences.com - Rasio rega marang bathi mangsa ngarep|Pangali Forward P/E CADL (Candel Therapeutics, Inc.)|Pangali Forward P/E Accuray Inc ARAY|SLS: Prakiraan rega marang bathi|Rasio prakiraan rega marang bathi Actuate Therapeutics Inc|CTOR: Pangali Forward P/E|TuHURA Biosciences (HURA) - Pangali Forward P/E|Prakiraan rega marang bathi TARA|FATE: Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E WHWK|Rega marang bathi mangsa ngarep TCRX (tscan.com)|Pangali Forward P/E CSBR (Champions Oncology, Inc.)|Kapitalisasi marang proyeksi bathi XBiotech Inc (XBIT)|CVM - Rega marang bathi mangsa ngarep|Rasio prakiraan rega marang bathi OS Therapies Inc.|Radiopharm Theranostics Limited (RADX) - Rega marang bathi mangsa ngarep|ARTV - Kapitalisasi marang proyeksi bathi|ANL (Adlai Nortye Ltd) - Pangali Forward P/E|Prakiraan rega marang bathi verupharma.com (VERU)|Pangali Forward P/E TPST|Kapitalisasi marang proyeksi bathi xiliotx.com|Pangali Forward P/E RENB (Renovaro)|Mural Oncology PLC (MURA) - Rasio prakiraan rega marang bathi|KAPA - Rega marang bathi mangsa ngarep|OKUR (OnKure Therapeutics Inc) - Rasio rega marang bathi mangsa ngarep|GDTC: Pangali Forward P/E|Prakiraan rega marang bathi Curis|APLM (Apollomics Inc.) - Pangali Forward P/E|Rasio prakiraan rega marang bathi Tharimmune Corporation THAR|Rega marang bathi mangsa ngarep Advanced Biomed Inc (ADVB)|Kapitalisasi marang proyeksi bathi genprex.com|Rega marang bathi mangsa ngarep Calidi Biotherapeutics, Inc. CLDI|SBFM: Rasio rega marang bathi mangsa ngarep|Xenetic Bio - Pangali Forward P/E|SLRX - Pangali Forward P/E|PPBT (Purple Biotech) - Prakiraan rega marang bathi|Rasio prakiraan rega marang bathi American Oncology Network, Inc. (AONC)|BGNE (BeiGene) - Pangali Forward P/E|Pangali Forward P/E Checkpoint Therapeutics Inc.|Pangali Forward P/E ELEV|Prakiraan rega marang bathi icadmed.com ICAD|Pangali Forward P/E IKNA (Ikena Oncology)|Pangali Forward P/E notablelabs.com NTBL|VIRX - Rega marang bathi mangsa ngarep|MOR (MorphoSys Inc) - Rasio rega marang bathi mangsa ngarep|AAPGV: Pangali Forward P/E
